At least half of all people with diabetes have some degree of microvascular complications

Eli Lilly and Company (NYSE: LLY - News) today announced key findings from two analyses of prior study data that may lead to improved outcomes for two major diabetic microvascular complications -- diabetic neuropathy and diabetic retinopathy. One study presented during the 64th Scientific Sessions of the American Diabetes Association (ADA) described the correlation between vibration detection testing -- a comfortable way of testing nerve function, and commonly used nerve conduction studies which are costly and associated with patient discomfort. A second set of data pinpointing a critical phase in the progression of diabetic macular edema, a complication of diabetic retinopathy, suggest that earlier treatment may minimize vision loss in people with diabetes.

The three major diabetic microvascular complications include diabetic neuropathy, diabetic retinopathy and diabetic nephropathy. Diabetic microvascular complications result from damage to the small blood vessels in the nerves, eyes and kidneys, and eventually lead to loss of function in these tissues.(1,2a-d,3) If undetected and untreated, these complications can potentially lead to severe organ damage possibly resulting in limb amputation, blindness, and kidney failure.

Read the whole article at Yahoo News: Key Study Findings About Diabetic Microvascular Complications May Lead to Improved Screenings and Treatment for People with Diabetes